Case study: Lessons learned in the care of a 63-year-old woman with type 2 diabetes

Clinical Cornerstone

Volumn 7, Issue SUPPL. 3, 2005, Pages

  Davidson, Jaime A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLIBENCLAMIDE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN DERIVATIVE; INSULIN GLARGINE; ISOPHANE INSULIN; METFORMIN;

ADULT; ARTICLE; AWARENESS; BLOOD GLUCOSE MONITORING; BODY WEIGHT DISORDER; CASE REPORT; DIABETES CONTROL; FEMALE; GLYCEMIC CONTROL; HUMAN; INSULIN HYPOGLYCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; RISK ASSESSMENT; SELF MONITORING; SYMPTOMATOLOGY; TREATMENT FAILURE; UNITED STATES; WEIGHT GAIN;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; MIDDLE AGED; RISK;

EID: 33644891696     PISSN: 10983597     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1098-3597(05)80085-7     Document Type: Article

References (29)

1. Koro C.E. Bowlin S.J. Bourgeois N. Fedder D.O. Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes Diabetes Care 27 2004 17-20
2. American Association of Clinical Endocrinologists Implementation Conference for ACE Outpatient Diabetes Mellitus Consensus Conference Recommendations: Position SHatement Available at: http://www.aace.com/pub/odimplementation/index.php Accessed November 9, 2005
3. American Diabetes Association Standards of medical care in diabetes Diabetes Care 28 2005 54-536
4. Available at: http://www.cadre-diabetes.org/em/pdf/newsletters/archive/ CADRE_newsletter_01.pdf Council for the Advancement of Diabetes Research and Education CADRE's A1C Position Accessed August 9, 2005 Curr Diabetes Pract. 1 2002 7
5. American Association of Clinical Endocrinologists and the American College of Endocrinology The American Association of Clinical Endocrinologists medical guidelines for the management of diabetes mellitus: The AACE system of intensive diabetes self-management - 2002 Update Endocr Pract. 8 Suppl 1 2002 40-82
6. Grant R.W. Cagliero E. Dubey A.K. et. al. Clinical inertia in the management of type 2 diabetes metabolic risk factors Diabet Med. 21 2004 150-155
7. Palumbo P. The case for insulin treatment early in type 2 diabetes Cleve Clin J Med. 71 2004 385-405
8. American Diabetes Association Economic consequences of diabetes mellitus in the U.S. in 1997 Diabetes Care 21 1998 296-309
9. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med. 329 1993 977-986
10. Ohkubo Y. Kishikawa H. Araki E. et. al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetesmellitus: A randomized prospective 6-year study Diabetes Res Clin Pract. 28 1995 103-117
11. United Kingdom Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type2 diabetes (UKPDS 33) Lancet 352 1998 837-853
12. Kuusisto J. Mykkanen L. Pyorala K. Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects Diabetes 43 1994 960-967
13. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes Diabetes Care 18 1995 258-268
14. Khaw K.T. Warham N. Luben R. et. al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk) Bmj 322 2001 1-6
15. Khaw K.T. Wareham N. Bingham S. et. al. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: The European Prospective Investigation into Cancer in Norfolk Ann Intern Med. 141 2004 413-420
16. Therapeutic Options: Secretogogues, Sensitizers, and Prandial Regulators. Council for the Advancement of Diabetes Research and Education (CADRE) Core Slide Kit/Section 5 http://www.cadrediabetes.org 2004
17. Gabriely I. Shamoon H. Hypoglycemia in diabetes: Common, often unrecognized Cleve Clin J Med. 71 2004 335-342
18. Patient Information: Hypoglycemia Cleve Clin J Med. 71 2004 343-344
19. Bolli G.B. How to ameliorate the problem of hypoglycemia in intensive as well as nonintensive treatment of type 1 diabetes Diabetes Care 22 1999 B43-B52
20. Chau D. Edelman S.V. Clinical management of diabetes in the elderly Clin Diabetes 19 2001 172-175
21. Saleh M. Grunberg G. Hypoglycemia: An excuse for poor glycemic control? Clin Diabetes 19 2001 161-167
22. Oiknine R. Bembaum M. Mooradian A.D. A critical appraisal of the role of insulin analogues in the management of diabetes mellitus Drugs 65 2005 325-340
23. Hirsch I.B. Insulin analogues N Engl J Med. 352 2005 174-183
24. Rosenstock J. Schwartz S. Clark C. et. al. Basal insulin therapy in type 2 diabetes: 28-Week comparison of insulin glargine (HOE 901) and NPH insulin Diabetes Care 24 2001 631-636
25. Thomas-Doversen D. Case study: A 64-year-old man with a 9-year history of type 2 diabetes in whom insulin therapy led to improved control but no weight gain after 6months Clin Diabetes 21 2003 190-192
26. 1c levels Curr Med Res Opin. 20 2004 1919-1927
27. Ramlo-Halsted B.A. Edelman S.V. The natural history of type 2 diabetes: Implications for clinical practice Primary Care 26 1999 771-789
28. (Suppl) Holman R.R. Assessing the potential for alpha-glucosidase inhibitors in prediabetic states Diabetes Res Clin Pract. 40 1998 S21-S25
29. [published correction appears in Diabetes. 1996;45:1655] UK Prospective Diabetes Study (UKPDS 16) Overview of 6 years' therapy of type 2 diabetes: A progressive disease Diabetes 44 1995 1249-1258